Hirono Iriuchishima

Dr. Hirono Iriuchishima


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2014 in European Journal of Haematology
Verified
Journal Article
Closed access
PDF file
HIHirono Iriuchishima
Hirono Iriuchishima
TSTakayuki Saitoh
Takayuki Saitoh
HHHiroshi Handa
Hiroshi Handa
AIAtsushi Isoda
Atsushi Isoda
MMMorio Matsumoto
Morio Matsumoto
YNYoshihisa Nojima
Yoshihisa Nojima

31 May 2019 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
HIHirono Iriuchishima
Hirono Iriuchishima
AMAkito Maeshima
Akito Maeshima
STShunsuke Takahashi
Shunsuke Takahashi
TITakuma Ishizaki
Takuma Ishizaki
AYAkihiko Yokohama
Akihiko Yokohama
HHHiroshi Handa
Hiroshi Handa
Renal impairment (RI) is a common complication of multiple myeloma (MM) that significantly affects treatment efficacy and mortality. However, no useful biomarkers for early detection of renal damage in MM exist. Reports indicate that activin A, a multifunctional cytokine of the TGF-β superfamily, is involved in the development and progression of various kidney diseases. In the present study, we measured urinary activin A levels in patients with newly diagnosed MM (NDMM) (n=41), smoldering MM (SMM) (n=10), and monoclonal gammopathy of undetermined significance (MGUS) (n=28), including monoclonal gammopathy of renal significance (MGRS), and assessed the correlation between urinary activin A and several clinical parameters. Urinary activin A, undetectable in healthy volunteers, was significantly increased in NDMM patients but not in patients with SMM and MGUS (97.3, 25.0, and 6.61 mg/gCr, respectively, P<0.05). In all patients with NDMM, urinary activin A levels were significantly reduced after initial treatment regardless of the therapy regimen. There was a significant correlation of urinary activin A with spot urinary protein level (P<0.001) and serum M-protein (P=0.029) but not with estimated glomerular filtration rate (eGFR), serum creatinine (Cr), N-acetyl-glucosaminidase (NAG), and serum activin A level. Histological analysis using renal biopsy samples revealed that activin A, which was absent from normal kidneys, was detected in the renal tubular cells of patients with MGRS. These data suggest that urinary activin A reflects tubular injury in MM and might aid the early detection of RI in plasma cell neoplasms.

1 January 2006 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
TSTakayuki Saitoh
Takayuki Saitoh
TMTakafumi Matsushima
Takafumi Matsushima
HIHirono Iriuchishima
Hirono Iriuchishima
AYArito Yamane
Arito Yamane
HIHiroyuki Irisawa
Hiroyuki Irisawa
HMHirokazu Murakami
Hirokazu Murakami
(2006). Presentation of extramedullary Philadelphia chromosome-positive biphenotypic acute leukemia as testicular mass: Response to imatinib-combined chemotherapy. Leukemia & Lymphoma: Vol. 47, No. 12, pp. 2667-2669.

29 March 2024 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
HIHirono Iriuchishima
Hirono Iriuchishima
ASAkio Saito
Akio Saito
MMMasahiro Mihara
Masahiro Mihara
YTYukie Terasaki
Yukie Terasaki
AMAkira Matsumoto
Akira Matsumoto
MMMorio Matsumoto
Morio Matsumoto

1 January 2015 in Japanese Journal of Transfusion and Cell Therapy
Verified
Journal Article
Closed access
TSTomomi Sekigami
Tomomi Sekigami
HIHirono Iriuchishima
Hirono Iriuchishima
MTMakiko Takizawa
Makiko Takizawa
TMTakayuki Maruhashi
Takayuki Maruhashi
KYKeiko Yokote
Keiko Yokote
AYAkihiko Yokohama
Akihiko Yokohama

1 June 2007
Verified
Journal Article
Closed access
HIHirono Iriuchishima
Hirono Iriuchishima
YOYoshiyuki Ogawa
Yoshiyuki Ogawa
THTakumi Hoshino
Takumi Hoshino
TYTakatomo Yoshida
Takatomo Yoshida
KSKen Sato
Ken Sato
TJTakahiro Jinbo
Takahiro Jinbo